Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125555702 | 12555570 | 2 | F | 20151215 | 20160712 | 20160714 | 20160715 | EXP | PHHY2016DE093598 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160716 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125555702 | 12555570 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | U | 22068 | 600 | MG | CAPSULE | QD | |||||
125555702 | 12555570 | 2 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 5 MG, UNK | 0 | 5 | MG | ||||||||
125555702 | 12555570 | 3 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 2.5 MG, UNK | 0 | 2.5 | MG | ||||||||
125555702 | 12555570 | 4 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | 100 MG, UNK | 0 | 100 | MG | ||||||||
125555702 | 12555570 | 5 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | 2.5 MG, UNK | 0 | 2.5 | MG | ||||||||
125555702 | 12555570 | 6 | C | TRIMIPRAMINE | TRIMIPRAMINE | 1 | Unknown | 8 MG, UNK | 0 | 8 | MG | ||||||||
125555702 | 12555570 | 7 | C | ESTRAMON | ESTRADIOL | 1 | Unknown | 25 UG, UNK | 0 | 25 | UG | ||||||||
125555702 | 12555570 | 8 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 500 MG, UNK | Y | 0 | 500 | MG | |||||||
125555702 | 12555570 | 9 | C | BLANEL | 2 | Unknown | UNK | 0 | EFFERVESCENT TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125555702 | 12555570 | 1 | Chronic myeloid leukaemia |
125555702 | 12555570 | 2 | Product used for unknown indication |
125555702 | 12555570 | 4 | Product used for unknown indication |
125555702 | 12555570 | 5 | Product used for unknown indication |
125555702 | 12555570 | 6 | Product used for unknown indication |
125555702 | 12555570 | 7 | Product used for unknown indication |
125555702 | 12555570 | 8 | Product used for unknown indication |
125555702 | 12555570 | 9 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125555702 | 12555570 | Abdominal pain lower | |
125555702 | 12555570 | Arthralgia | |
125555702 | 12555570 | Calculus urinary | |
125555702 | 12555570 | Dyspnoea exertional | |
125555702 | 12555570 | Eye irritation | |
125555702 | 12555570 | Gastritis | |
125555702 | 12555570 | Nasopharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125555702 | 12555570 | 1 | 20150714 | 0 | ||
125555702 | 12555570 | 2 | 2013 | 20150810 | 0 | |
125555702 | 12555570 | 3 | 20150810 | 0 | ||
125555702 | 12555570 | 4 | 2012 | 0 | ||
125555702 | 12555570 | 5 | 2012 | 0 | ||
125555702 | 12555570 | 6 | 2012 | 0 | ||
125555702 | 12555570 | 7 | 20150810 | 0 | ||
125555702 | 12555570 | 8 | 20160328 | 20160418 | 0 | |
125555702 | 12555570 | 9 | 201604 | 0 |